Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Berthold

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
MMW Fortschritte Der Medizin|October 7, 2019
[Oral anticoagulation in atrial fibrillation: differential therapy with non vitamin K antagonist oral anticoagulants (NOAC) and vitamin K antagonists (VKA)]Christoph Sucker, Jens Litmathe, Heiner K Berthold
European Journal of Nutrition|February 6, 2019
Serum 25-hydroxyvitamin D response to vitamin D supplementation in infants: a systematic review and meta-analysis of clinical intervention trialsArmin Zittermann, Stefan Pilz, Heiner K Berthold
Calcified Tissue International|July 23, 2003
Carbamazepine does not alter biochemical parameters of bone turnover in healthy male adultsS Brämswig, A Zittermann, H K Berthold
Acta Endocrinologica|March 1, 1970
Comparison of effects of 6-dehydro-16-methylene-hydrocortisone (STC 407) and dexamethasone on the suppression of the hypothalamo-pituitary-adrenal systemK Berthold, A Arimura, A V Schally
European Journal of Clinical Nutrition|May 14, 2021
Reply to Meshkini et alArmin Zittermann, Heiner K Berthold, Stefan Pilz
Current Atherosclerosis Reports|July 28, 2022
PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid-Based Therapy EraIoanna Gouni-Berthold, Jonas Schwarz, Heiner K Berthold
Chemico-Biological Interactions|January 1, 1988
Bacterial cysteine conjugate beta-lyase and the metabolism of cysteine S-conjugates: structural requirements for the cleavage of S-conjugates and the formation of reactive intermediatesS Vamvakas, K Berthold, W Dekant, et al.
Current Atherosclerosis Reports|August 29, 2023
Updates in Drug Treatment of Severe HypertriglyceridemiaIoanna Gouni-Berthold, Jonas Schwarz, Heiner K Berthold
Chemico-Biological Interactions|January 1, 1988
Thioacylating agents as ultimate intermediates in the beta-lyase catalysed metabolism of S-(pentachloro-butadienyl)-L-cysteineW Dekant, K Berthold, S Vamvakas, et al.
Chemico-Biological Interactions|January 1, 1989
Cytotoxicity of cysteine S-conjugates: structure-activity relationshipsS Vamvakas, A Köchling, K Berthold, et al.
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
MMW Fortschritte Der Medizin|October 7, 2019
[Oral anticoagulation in atrial fibrillation: differential therapy with non vitamin K antagonist oral anticoagulants (NOAC) and vitamin K antagonists (VKA)]Christoph Sucker, Jens Litmathe, Heiner K Berthold
European Journal of Nutrition|February 6, 2019
Serum 25-hydroxyvitamin D response to vitamin D supplementation in infants: a systematic review and meta-analysis of clinical intervention trialsArmin Zittermann, Stefan Pilz, Heiner K Berthold
Calcified Tissue International|July 23, 2003
Carbamazepine does not alter biochemical parameters of bone turnover in healthy male adultsS Brämswig, A Zittermann, H K Berthold
Acta Endocrinologica|March 1, 1970
Comparison of effects of 6-dehydro-16-methylene-hydrocortisone (STC 407) and dexamethasone on the suppression of the hypothalamo-pituitary-adrenal systemK Berthold, A Arimura, A V Schally
European Journal of Clinical Nutrition|May 14, 2021
Reply to Meshkini et alArmin Zittermann, Heiner K Berthold, Stefan Pilz
Current Atherosclerosis Reports|July 28, 2022
PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid-Based Therapy EraIoanna Gouni-Berthold, Jonas Schwarz, Heiner K Berthold
Chemico-Biological Interactions|January 1, 1988
Bacterial cysteine conjugate beta-lyase and the metabolism of cysteine S-conjugates: structural requirements for the cleavage of S-conjugates and the formation of reactive intermediatesS Vamvakas, K Berthold, W Dekant, et al.
Current Atherosclerosis Reports|August 29, 2023
Updates in Drug Treatment of Severe HypertriglyceridemiaIoanna Gouni-Berthold, Jonas Schwarz, Heiner K Berthold
Chemico-Biological Interactions|January 1, 1988
Thioacylating agents as ultimate intermediates in the beta-lyase catalysed metabolism of S-(pentachloro-butadienyl)-L-cysteineW Dekant, K Berthold, S Vamvakas, et al.
Chemico-Biological Interactions|January 1, 1989
Cytotoxicity of cysteine S-conjugates: structure-activity relationshipsS Vamvakas, A Köchling, K Berthold, et al.
Pageof 17